MindMed NEO:MMED

Mindmed is developing therapeutic treatments from psychedelic substances to improve health and wellness. Assembling the most compelling IP portfolio of psychedelic inspired medicines for FDA clinical trials & commercialization.

The legalization of psychedelic inspired medicines will be different than cannabis. FDA will regulate as drug therapies using clinical trials.

Related Posts